Marqeta (MQ) is drawing attention after recent trading left the stock at US$4.08, with a 1 day return of 3.8% and mixed performance over the month and the past 3 months.
See our latest analysis for Marqeta.
That 3.8% 1 day share price return comes after a weaker run, with the 30 day share price return of 3.8% and the year to date share price return of 12.1% both well behind the 3 year total shareholder return of 14.3%. This suggests recent momentum has faded even though longer term holders still see a positive overall outcome.
If recent payment technology moves have your attention, it can be a good moment to scan for other high growth themes and uncover 64 profitable AI stocks that aren't just burning cash
So, with Marqeta showing a mix of recent share price weakness, revenue growth of 12.1%, and annual net income growth that is a very large figure, is the current US$4.08 price a fresh entry point, or is future growth already fully reflected?
Most Popular Narrative: 28.8% Undervalued
Against the last close at $4.08, the most followed narrative points to a fair value of about $5.73, using a 7.23% discount rate and detailed long term forecasts.
The completed TransactPay acquisition gives Marqeta full program management and EMI capabilities in Europe, enabling entry into larger enterprise opportunities, uniformity of service across North America and Europe, and easier multi market expansion for clients. This unlocks new revenue streams, increases take rates, and improves earnings scalability.
Curious what earnings path, margin profile, and future valuation multiple need to line up for that fair value to hold? The narrative leans on a specific mix of revenue growth expectations, improving profitability and a premium earnings multiple that is more typical of faster growing fintech names, all baked into that 7.23% discount rate and a multi year forecast horizon.
Result: Fair Value of $5.73 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on key risks, including heavy reliance on major clients like Block and rising competition in card issuing that could pressure margins and growth assumptions.
Find out about the key risks to this Marqeta narrative.
Another View: Market Ratios Point the Other Way
That 28.8% undervaluation story sits awkwardly next to how the market is actually pricing Marqeta today. The current P/S ratio is 2.8x, compared with 2.3x for the US Diversified Financial industry, 1.6x for peers, and a fair ratio estimate of 2.2x, so the stock looks expensive rather than cheap on this lens.
If the market eventually leans back toward that lower fair ratio, valuation could compress instead of expanding in the way the growth narrative assumes. The key question is which signal carries more weight: the optimistic growth model or the cooler read from today’s revenue multiple?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With one narrative pointing to upside and another hinting at a richer valuation, it is worth checking the numbers yourself before taking a view. To see what has investors optimistic and how that compares with your own expectations, review the company’s 1 key reward
Looking for more investment ideas?
If Marqeta has sharpened your thinking, do not stop here. The screener can help you spot other candidates that fit your style before the crowd catches on.
- Target potential mispricings by scanning 53 high quality undervalued stocks that combine solid fundamentals with prices that may not fully reflect their qualities.
- Prioritise resilience by focusing on 68 resilient stocks with low risk scores that score well on financial strength and business stability.
- Hunt for fresh opportunities with the screener containing 26 high quality undiscovered gems that have strong metrics but limited market attention so far.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com